1. Price, L.A., Hill, B.T.: Impact of primary site of stage III and IV squamous cell carcinoma of the head and neck on 7-year survival figures following initial non-cisplatin-containing combination chemotherapy. Recent Results Cancer Res.103:124, 1986
2. Donadio, M., Bonardi, G., Iberti, V., Bertetto, O., Carnino, F., Iskra, L., Mossetti, C., Calciati, A.: The role of induction chemotherapy in inoperable ovarian cancer. Tumori75:609, 1989
3. Hong, W.K., Pennachio, J., Shapsay, S., Vaughan, C., Katz, A., Bhutani, R., Bromer, R., Willett, B., Strong, S.: Adjuvant chemotherapy with cis-platinum and bleomycin infusion prior to definitive treatment for advanced stage III and IV squamous cell head and neck carcinoma. In Adjuvant Therapy of Cancer, Vol. III, S.E. Salmon, S.E. Jones, editors. Orlando, FL, Grune & Stratton, 1981, pp. 153–160
4. Preusseur, P., Wike, H., Fink, U., Meyer, J., Meyer, H.G., Loo, J.: Phase-2-Studie mit Etoposid, Adriamycin, Cisplatin (EAP) beim primar inoperablen, metastasierten Magenkarzinom. Tumor Diagn Ther8:43, 1987
5. Plucker, J.T., Mulder, N.H., Sleijfer, D.T., Grond, J., Verschueren, R.C.J.: Chemotherapy and surgery for locally advanced cancer of the cardia and fundus: phase II study with methotrexate and 5-fluorouracil. Br. J. Surg.78:955, 1991